Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
MY TRIALS
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Register a trial
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT02592369
Registration number
NCT02592369
Ethics application status
Date submitted
20/10/2015
Date registered
30/10/2015
Titles & IDs
Public title
CoreValve™ Evolut R™ FORWARD Study
Query!
Scientific title
The Medtronic CoreValve™ Evolut R™ FORWARD Study
Query!
Secondary ID [1]
0
0
Evolut R™ FORWARD Study
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
FORWARD
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Aortic Valve Stenosis
0
0
Query!
Condition category
Condition code
Cardiovascular
0
0
0
0
Query!
Diseases of the vasculature and circulation including the lymphatic system
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
Treatment: Devices - Medtronic CoreValve™ Evolut R™ System
Treatment: Devices: Medtronic CoreValve™ Evolut R™ System
The Evolut R System is intended for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a heart team, to be at high or extreme risk for open heart surgery. The Evolut R TAV treats aortic stenosis by displacing and functionally replacing the dysfunctional native valve with a bioprosthetic valve delivered on a catheter while the heart is still beating, thus avoiding the risks of cardiopulmonary bypass. Its intended performance is to relieve aortic valve stenosis without inducing significant regurgitation, thereby restoring effective aortic valve function.
Query!
Intervention code [1]
0
0
Treatment: Devices
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
All-cause mortality rate
Query!
Assessment method [1]
0
0
All-cause mortality rate at 30 days post procedure
Query!
Timepoint [1]
0
0
30 days post implant
Query!
Secondary outcome [1]
0
0
Device success according to VARC2
Query!
Assessment method [1]
0
0
Device success rate at 24 hours to 7 days, defined according to the Valve Academic Research Consortium-2 (VARC-2) guidelines as:
* Absence of procedural mortality, AND
* Correct positioning of a single prosthetic heart valve into the proper anatomical location, AND
* Intended performance of the prosthetic heart valve, defined as the absence of patient-prosthesis mismatch and mean gradient \< 20 mmHg (or peak velocity \< 3 m/sec), AND No moderate or severe prosthetic valve regurgitation.
Query!
Timepoint [1]
0
0
24h to 7 days post implant
Query!
Secondary outcome [2]
0
0
Hemodynamic performance
Query!
Assessment method [2]
0
0
Hemodynamic performance at 24 hours to 7 days (discharge) and 1 year post procedure, including the mean prosthetic valve gradient as measured by transthoracic echocardiography (TTE) and assessed by an independent core laboratory.
Query!
Timepoint [2]
0
0
24h to 7 days and 1 year post implant
Query!
Secondary outcome [3]
0
0
Hemodynamic performance
Query!
Assessment method [3]
0
0
Hemodynamic performance at 24 hours to 7 days (discharge) and 1 year post procedure, including the effective orifice area as measured by transthoracic echocardiography (TTE) and assessed by an independent core laboratory.
Query!
Timepoint [3]
0
0
24h to 7 days and 1 year post implant
Query!
Secondary outcome [4]
0
0
Hemodynamic performance
Query!
Assessment method [4]
0
0
Hemodynamic performance at 24 hours to 7 days (discharge) and 1 year post procedure, including the degree of prosthetic valve regurgitation (transvalvular, paravalvular, and total) as measured by transthoracic echocardiography (TTE) and assessed by an independent core laboratory.
Query!
Timepoint [4]
0
0
24h to 7 days and 1 year post implant
Query!
Secondary outcome [5]
0
0
Early safety composite endpoint according to VARC2
Query!
Assessment method [5]
0
0
Early Safety composite endpoint at 30 days post procedure, defined according to the VARC-2 guidelines, defined as any of the following components:
* All-cause mortality
* All stroke (disabling and non-disabling)
* Life-threatening bleeding
* Acute kidney injury: stage 2 or 3 (including renal replacement therapy)
* Coronary artery obstruction requiring intervention
* Major vascular complication
* Valve-related dysfunction requiring repeat procedure (BAV, TAVI, or SAVR)
Query!
Timepoint [5]
0
0
30 days post implant
Query!
Secondary outcome [6]
0
0
Event rates according to VARC2
Query!
Assessment method [6]
0
0
Event rates of the individual components of the VARC-2 composite Early Safety endpoint at 30 days post procedure
Query!
Timepoint [6]
0
0
30 days post implant
Query!
Secondary outcome [7]
0
0
Rate of new permanent pacemaker implant
Query!
Assessment method [7]
0
0
Rate of new permanent pacemaker implant at 30 days post procedure
Query!
Timepoint [7]
0
0
30 days post implant
Query!
Eligibility
Key inclusion criteria
* Symptomatic native aortic valve stenosis or a stenosed, insufficient, or combined surgical bioprosthetic valve failure necessitating valve replacement
* Acceptable candidate for elective treatment with the Evolut R System and in conformity with the local regulatory and medico economic context
* Age =80 years OR considered to be at high or greater risk for surgical aortic valve replacement (AVR) where high risk is defined as:
* Society of Thoracic Surgeons (STS) predicted risk of mortality =8% OR
* Documented heart team agreement of risk for AVR due to frailty or comorbidities.
* Geographically stable and willing to return to the implanting site for all follow-up visits
* Of legal age to provide informed consent (patient Informed Consent or Data Release Form) in the country where they enroll in the trial
* The patient has been informed of the nature of the study, is able and willing to provide consent without assistance from a legal representative and has consented to participate, and has authorized the collection and release of his/her medical information by signing a Patient Informed Consent or Data Release Form.
Query!
Minimum age
No limit
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
* Known hypersensitivity or contraindication to aspirin, heparin (HIT/HITTS) and bivalirudin, ticlopidine, clopidogrel, Nitinol (Titanium or Nickel), or sensitivity to contrast media, which cannot be adequately premedicated
* Preexisting mechanical heart valve in aortic position
* Ongoing sepsis, including active endocarditis
* Anatomically not suitable for the Evolut R system
* Estimated life expectancy of less than 1 year
* Participating in another trial that may influence the outcome of this trial
* Need for emergency surgery for any reason
Query!
Study design
Purpose
Query!
Duration
Query!
Selection
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/01/2016
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
6/02/2020
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
1060
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Recruitment hospital [1]
0
0
Flinders Medical Centre - Adelaide
Query!
Recruitment hospital [2]
0
0
Monash Medical Centre - Melbourne
Query!
Recruitment hospital [3]
0
0
The Alfred Hospital - Melbourne
Query!
Recruitment hospital [4]
0
0
Fiona Stanley Hospital Perth - Perth
Query!
Recruitment postcode(s) [1]
0
0
- Adelaide
Query!
Recruitment postcode(s) [2]
0
0
- Melbourne
Query!
Recruitment postcode(s) [3]
0
0
- Perth
Query!
Recruitment outside Australia
Country [1]
0
0
Belgium
Query!
State/province [1]
0
0
Antwerpen
Query!
Country [2]
0
0
Canada
Query!
State/province [2]
0
0
London
Query!
Country [3]
0
0
Canada
Query!
State/province [3]
0
0
Toronto
Query!
Country [4]
0
0
Canada
Query!
State/province [4]
0
0
Vancouver
Query!
Country [5]
0
0
Colombia
Query!
State/province [5]
0
0
Cali
Query!
Country [6]
0
0
Czechia
Query!
State/province [6]
0
0
Trinec
Query!
Country [7]
0
0
France
Query!
State/province [7]
0
0
Creteil
Query!
Country [8]
0
0
France
Query!
State/province [8]
0
0
Lille
Query!
Country [9]
0
0
France
Query!
State/province [9]
0
0
Massy
Query!
Country [10]
0
0
France
Query!
State/province [10]
0
0
Paris
Query!
Country [11]
0
0
France
Query!
State/province [11]
0
0
Toulouse
Query!
Country [12]
0
0
Germany
Query!
State/province [12]
0
0
Bad Oeynhausen
Query!
Country [13]
0
0
Germany
Query!
State/province [13]
0
0
Berlin
Query!
Country [14]
0
0
Germany
Query!
State/province [14]
0
0
Bonn
Query!
Country [15]
0
0
Germany
Query!
State/province [15]
0
0
Cottbus
Query!
Country [16]
0
0
Germany
Query!
State/province [16]
0
0
Dresden
Query!
Country [17]
0
0
Germany
Query!
State/province [17]
0
0
Duesseldorf
Query!
Country [18]
0
0
Germany
Query!
State/province [18]
0
0
Essen
Query!
Country [19]
0
0
Germany
Query!
State/province [19]
0
0
Frankfurt
Query!
Country [20]
0
0
Germany
Query!
State/province [20]
0
0
Hamburg
Query!
Country [21]
0
0
Germany
Query!
State/province [21]
0
0
Karlsruhe
Query!
Country [22]
0
0
Germany
Query!
State/province [22]
0
0
Leipzig
Query!
Country [23]
0
0
Germany
Query!
State/province [23]
0
0
Munich
Query!
Country [24]
0
0
Greece
Query!
State/province [24]
0
0
Athens
Query!
Country [25]
0
0
Hungary
Query!
State/province [25]
0
0
Budapest
Query!
Country [26]
0
0
Israel
Query!
State/province [26]
0
0
Tel-Aviv
Query!
Country [27]
0
0
Italy
Query!
State/province [27]
0
0
Brescia
Query!
Country [28]
0
0
Italy
Query!
State/province [28]
0
0
Catania
Query!
Country [29]
0
0
Italy
Query!
State/province [29]
0
0
Milan
Query!
Country [30]
0
0
Italy
Query!
State/province [30]
0
0
Pisa
Query!
Country [31]
0
0
Netherlands
Query!
State/province [31]
0
0
Amsterdam
Query!
Country [32]
0
0
Netherlands
Query!
State/province [32]
0
0
Eindhoven
Query!
Country [33]
0
0
Netherlands
Query!
State/province [33]
0
0
Nieuwegein
Query!
Country [34]
0
0
Netherlands
Query!
State/province [34]
0
0
Rotterdam
Query!
Country [35]
0
0
Norway
Query!
State/province [35]
0
0
Oslo
Query!
Country [36]
0
0
Panama
Query!
State/province [36]
0
0
Panama
Query!
Country [37]
0
0
Poland
Query!
State/province [37]
0
0
Warsaw
Query!
Country [38]
0
0
Portugal
Query!
State/province [38]
0
0
Vila Nova de Gaia
Query!
Country [39]
0
0
Saudi Arabia
Query!
State/province [39]
0
0
Riyadh
Query!
Country [40]
0
0
South Africa
Query!
State/province [40]
0
0
Cape Town
Query!
Country [41]
0
0
Spain
Query!
State/province [41]
0
0
Malaga
Query!
Country [42]
0
0
Spain
Query!
State/province [42]
0
0
Oviedo
Query!
Country [43]
0
0
Spain
Query!
State/province [43]
0
0
Santiago de Compostela
Query!
Country [44]
0
0
Sweden
Query!
State/province [44]
0
0
Uppsala
Query!
Country [45]
0
0
United Kingdom
Query!
State/province [45]
0
0
Belfast
Query!
Country [46]
0
0
United Kingdom
Query!
State/province [46]
0
0
Brighton
Query!
Country [47]
0
0
United Kingdom
Query!
State/province [47]
0
0
Leeds
Query!
Country [48]
0
0
United Kingdom
Query!
State/province [48]
0
0
Wolverhampton
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Query!
Name
Medtronic Cardiovascular
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
Prospective, single arm, multi-center, observational, post market study to document the clinical and device performance outcomes of the Evolut R system used in routine hospital practice in a large patient cohort for the treatment of symptomatic native aortic valve stenosis or a stenosed, insufficient, or combined surgical bioprosthetic valve failure necessitating valve replacement.
Query!
Trial website
https://clinicaltrials.gov/study/NCT02592369
Query!
Trial related presentations / publications
Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochelliere R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010 Mar 16;55(11):1080-90. doi: 10.1016/j.jacc.2009.12.014. Epub 2010 Jan 22. Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010 Jul 6;122(1):62-9. doi: 10.1161/CIRCULATIONAHA.109.907402. Epub 2010 Jun 21. Lefevre T, Kappetein AP, Wolner E, Nataf P, Thomas M, Schachinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Serruys P, Wimmer-Greinecker G; PARTNER EU Investigator Group. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J. 2011 Jan;32(2):148-57. doi: 10.1093/eurheartj/ehq427. Epub 2010 Nov 12. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010 Oct 21;363(17):1597-607. doi: 10.1056/NEJMoa1008232. Epub 2010 Sep 22. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011 Jun 9;364(23):2187-98. doi: 10.1056/NEJMoa1103510. Epub 2011 Jun 5. Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, Hermiller J Jr, Hughes GC, Harrison JK, Coselli J, Diez J, Kafi A, Schreiber T, Gleason TG, Conte J, Buchbinder M, Deeb GM, Carabello B, Serruys PW, Chenoweth S, Oh JK; CoreValve United States Clinical Investigators. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014 May 20;63(19):1972-81. doi: 10.1016/j.jacc.2014.02.556. Epub 2014 Mar 19. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK; U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014 May 8;370(19):1790-8. doi: 10.1056/NEJMoa1400590. Epub 2014 Mar 29. Webb JG, Wood DA. Current status of transcatheter aortic valve replacement. J Am Coll Cardiol. 2012 Aug 7;60(6):483-92. doi: 10.1016/j.jacc.2012.01.071. Epub 2012 Jun 27. Genereux P, Head SJ, Wood DA, Kodali SK, Williams MR, Paradis JM, Spaziano M, Kappetein AP, Webb JG, Cribier A, Leon MB. Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur Heart J. 2012 Oct;33(19):2388-98. doi: 10.1093/eurheartj/ehs220. Epub 2012 Jul 31. Buellesfeld L, Gerckens U, Schuler G, Bonan R, Kovac J, Serruys PW, Labinaz M, den Heijer P, Mullen M, Tymchak W, Windecker S, Mueller R, Grube E. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol. 2011 Apr 19;57(16):1650-7. doi: 10.1016/j.jacc.2010.11.044. Ussia GP, Barbanti M, Petronio AS, Tarantini G, Ettori F, Colombo A, Violini R, Ramondo A, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, De Carlo M, Napodano M, Fiorina C, De Marco F, Antoniucci D, de Cillis E, Capodanno D, Tamburino C; CoreValve Italian Registry Investigators. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J. 2012 Apr;33(8):969-76. doi: 10.1093/eurheartj/ehr491. Epub 2012 Jan 12. Walther T, Dewey T, Borger MA, Kempfert J, Linke A, Becht R, Falk V, Schuler G, Mohr FW, Mack M. Transapical aortic valve implantation: step by step. Ann Thorac Surg. 2009 Jan;87(1):276-83. doi: 10.1016/j.athoracsur.2008.08.017. Walther T, Mollmann H, van Linden A, Kempfert J. Transcatheter aortic valve implantation transapical: step by step. Semin Thorac Cardiovasc Surg. 2011 Spring;23(1):55-61. doi: 10.1053/j.semtcvs.2011.05.006. Lange R, Bleiziffer S, Piazza N, Mazzitelli D, Hutter A, Tassani-Prell P, Laborde JC, Bauernschmitt R. Incidence and treatment of procedural cardiovascular complications associated with trans-arterial and trans-apical interventional aortic valve implantation in 412 consecutive patients. Eur J Cardiothorac Surg. 2011 Nov;40(5):1105-13. doi: 10.1016/j.ejcts.2011.03.022. Epub 2011 Apr 22. Miller DC, Blackstone EH, Mack MJ, Svensson LG, Kodali SK, Kapadia S, Rajeswaran J, Anderson WN, Moses JW, Tuzcu EM, Webb JG, Leon MB, Smith CR; PARTNER Trial Investigators and Patients; PARTNER Stroke Substudy Writing Group and Executive Committee. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg. 2012 Apr;143(4):832-843.e13. doi: 10.1016/j.jtcvs.2012.01.055. Eggebrecht H, Schmermund A, Voigtlander T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012 May 15;8(1):129-38. doi: 10.4244/EIJV8I1A20. Nuis RJ, Van Mieghem NM, Schultz CJ, Moelker A, van der Boon RM, van Geuns RJ, van der Lugt A, Serruys PW, Rodes-Cabau J, van Domburg RT, Koudstaal PJ, de Jaegere PP. Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am J Cardiol. 2012 Jun 1;109(11):1637-43. doi: 10.1016/j.amjcard.2012.01.389. Epub 2012 Mar 15. Sinning JM, Hammerstingl C, Vasa-Nicotera M, Adenauer V, Lema Cachiguango SJ, Scheer AC, Hausen S, Sedaghat A, Ghanem A, Muller C, Grube E, Nickenig G, Werner N. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J Am Coll Cardiol. 2012 Mar 27;59(13):1134-41. doi: 10.1016/j.jacc.2011.11.048. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012 May 3;366(18):1686-95. doi: 10.1056/NEJMoa1200384. Epub 2012 Mar 26. Tchetche D, Dumonteil N, Sauguet A, Descoutures F, Luz A, Garcia O, Soula P, Gabiache Y, Fournial G, Marcheix B, Carrie D, Fajadet J. Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population. EuroIntervention. 2010 Jan;5(6):659-65. doi: 10.4244/eijv5i6a109. Van Mieghem NM, Nuis RJ, Piazza N, Apostolos T, Ligthart J, Schultz C, de Jaegere PP, Serruys PW. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. EuroIntervention. 2010 Jan;5(6):673-9. doi: 10.4244/eijv5i6a111. Piazza N, Nuis RJ, Tzikas A, Otten A, Onuma Y, Garcia-Garcia H, Schultz C, van Domburg R, van Es GA, van Geuns R, de Jaegere P, Serruys PW. Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. EuroIntervention. 2010 Sep;6(4):475-84. doi: 10.4244/EIJ30V6I4A80. Fraccaro C, Buja G, Tarantini G, Gasparetto V, Leoni L, Razzolini R, Corrado D, Bonato R, Basso C, Thiene G, Gerosa G, Isabella G, Iliceto S, Napodano M. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol. 2011 Mar 1;107(5):747-54. doi: 10.1016/j.amjcard.2010.10.054. Epub 2011 Jan 19. van der Boon RM, Nuis RJ, Van Mieghem NM, Jordaens L, Rodes-Cabau J, van Domburg RT, Serruys PW, Anderson RH, de Jaegere PP. New conduction abnormalities after TAVI--frequency and causes. Nat Rev Cardiol. 2012 May 1;9(8):454-63. doi: 10.1038/nrcardio.2012.58. Tzikas A, van Dalen BM, Van Mieghem NM, Gutierrez-Chico JL, Nuis RJ, Kauer F, Schultz C, Serruys PW, de Jaegere PP, Geleijnse ML. Frequency of conduction abnormalities after transcatheter aortic valve implantation with the Medtronic-CoreValve and the effect on left ventricular ejection fraction. Am J Cardiol. 2011 Jan 15;107(2):285-9. doi: 10.1016/j.amjcard.2010.09.015. Epub 2010 Dec 2. Sherif MA, Abdel-Wahab M, Stocker B, Geist V, Richardt D, Tolg R, Richardt G. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol. 2010 Nov 9;56(20):1623-9. doi: 10.1016/j.jacc.2010.06.035. Takagi K, Latib A, Al-Lamee R, Mussardo M, Montorfano M, Maisano F, Godino C, Chieffo A, Alfieri O, Colombo A. Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation. Catheter Cardiovasc Interv. 2011 Sep 1;78(3):432-43. doi: 10.1002/ccd.23003. Epub 2011 Jul 25. Manoharan G, Van Mieghem NM, Windecker S, Bosmans J, Bleiziffer S, Modine T, Linke A, Scholtz W, Chevalier B, Gooley R, Zeng C, Oh JK, Grube E. 1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study. JACC Cardiovasc Interv. 2018 Nov 26;11(22):2326-2334. doi: 10.1016/j.jcin.2018.07.032. Grube E, Van Mieghem NM, Bleiziffer S, Modine T, Bosmans J, Manoharan G, Linke A, Scholtz W, Tchetche D, Finkelstein A, Trillo R, Fiorina C, Walton A, Malkin CJ, Oh JK, Qiao H, Windecker S; FORWARD Study Investigators. Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study. J Am Coll Cardiol. 2017 Aug 15;70(7):845-853. doi: 10.1016/j.jacc.2017.06.045.
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Eberhard Grube, Prof. Dr.
Query!
Address
0
0
University Hospital, Bonn
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Undecided
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Type
Other Details
Attachment
Study protocol
https://cdn.clinicaltrials.gov/large-docs/69/NCT02592369/Prot_000.pdf
Statistical analysis plan
https://cdn.clinicaltrials.gov/large-docs/69/NCT02592369/SAP_001.pdf
Informed consent form
Informed Consent Form: Informed Consent Form
https://cdn.clinicaltrials.gov/large-docs/69/NCT02592369/ICF_002.pdf
Informed consent form
Informed Consent Form: Data Release Form
https://cdn.clinicaltrials.gov/large-docs/69/NCT02592369/ICF_003.pdf
Results publications and other study-related documents
Type
Citations or Other Details
Journal
Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, ...
[
More Details
]
Journal
Thomas M, Schymik G, Walther T, Himbert D, Lefevre...
[
More Details
]
Journal
Lefevre T, Kappetein AP, Wolner E, Nataf P, Thomas...
[
More Details
]
Journal
Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Sv...
[
More Details
]
Journal
Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, S...
[
More Details
]
Journal
Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleima...
[
More Details
]
Journal
Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Cosell...
[
More Details
]
Journal
Webb JG, Wood DA. Current status of transcatheter ...
[
More Details
]
Journal
Genereux P, Head SJ, Wood DA, Kodali SK, Williams ...
[
More Details
]
Journal
Buellesfeld L, Gerckens U, Schuler G, Bonan R, Kov...
[
More Details
]
Journal
Ussia GP, Barbanti M, Petronio AS, Tarantini G, Et...
[
More Details
]
Journal
Walther T, Dewey T, Borger MA, Kempfert J, Linke A...
[
More Details
]
Journal
Walther T, Mollmann H, van Linden A, Kempfert J. T...
[
More Details
]
Journal
Lange R, Bleiziffer S, Piazza N, Mazzitelli D, Hut...
[
More Details
]
Journal
Miller DC, Blackstone EH, Mack MJ, Svensson LG, Ko...
[
More Details
]
Journal
Eggebrecht H, Schmermund A, Voigtlander T, Kahlert...
[
More Details
]
Journal
Nuis RJ, Van Mieghem NM, Schultz CJ, Moelker A, va...
[
More Details
]
Journal
Sinning JM, Hammerstingl C, Vasa-Nicotera M, Adena...
[
More Details
]
Journal
Kodali SK, Williams MR, Smith CR, Svensson LG, Web...
[
More Details
]
Journal
Tchetche D, Dumonteil N, Sauguet A, Descoutures F,...
[
More Details
]
Journal
Van Mieghem NM, Nuis RJ, Piazza N, Apostolos T, Li...
[
More Details
]
Journal
Piazza N, Nuis RJ, Tzikas A, Otten A, Onuma Y, Gar...
[
More Details
]
Journal
Fraccaro C, Buja G, Tarantini G, Gasparetto V, Leo...
[
More Details
]
Journal
van der Boon RM, Nuis RJ, Van Mieghem NM, Jordaens...
[
More Details
]
Journal
Tzikas A, van Dalen BM, Van Mieghem NM, Gutierrez-...
[
More Details
]
Journal
Sherif MA, Abdel-Wahab M, Stocker B, Geist V, Rich...
[
More Details
]
Journal
Takagi K, Latib A, Al-Lamee R, Mussardo M, Montorf...
[
More Details
]
Results not provided in
https://clinicaltrials.gov/study/NCT02592369